← Evidence map

ReviewTherapeutic innovation & regulatory science2021

Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development.

Timothé Ménard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34046876